Tetsuya Fujikawa

495 total citations
36 papers, 315 citations indexed

About

Tetsuya Fujikawa is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Hematology. According to data from OpenAlex, Tetsuya Fujikawa has authored 36 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 6 papers in Hematology. Recurrent topics in Tetsuya Fujikawa's work include Blood Pressure and Hypertension Studies (11 papers), Heart Rate Variability and Autonomic Control (10 papers) and Cardiovascular Health and Disease Prevention (8 papers). Tetsuya Fujikawa is often cited by papers focused on Blood Pressure and Hypertension Studies (11 papers), Heart Rate Variability and Autonomic Control (10 papers) and Cardiovascular Health and Disease Prevention (8 papers). Tetsuya Fujikawa collaborates with scholars based in Japan, Singapore and United States. Tetsuya Fujikawa's co-authors include Satoshi Umemura, Yoshiyuki Toya, Kouichi Tamura, Hiromichi Wakui, Kengo Azushima, Masato Ohsawa, Tomohiko Kanaoka, Osamu Tochikubo, Akinobu Maeda and Kazushi Uneda and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Tetsuya Fujikawa

35 papers receiving 310 citations

Peers

Tetsuya Fujikawa

CCM

NEPHR

HEMAT

SURGE

M Kuramochi Japan

Laura Zingaro Italy

Masatsugu Kishida Japan

Jonathan Baird-Gunning Australia

Krystian Josiak Poland

Dong-Rui Chen China

Dorota Polak‐Jonkisz Poland

P Gazzetti Italy

M Miltényi Hungary

Franco Perazzoli Italy

M Kuramochi Japan

Tetsuya Fujikawa

247 ×2.1

CCM

55 ×0.7

NEPHR

46 ×0.8

HEMAT

124 ×2.2

SURGE

70 ×1.5

Citations per year, relative to Tetsuya Fujikawa Tetsuya Fujikawa (= 1×) peers M Kuramochi

Countries citing papers authored by Tetsuya Fujikawa

Since Specialization

Citations

This map shows the geographic impact of Tetsuya Fujikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Fujikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Fujikawa more than expected).

Fields of papers citing papers by Tetsuya Fujikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Fujikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Fujikawa. The network helps show where Tetsuya Fujikawa may publish in the future.

Co-authorship network of co-authors of Tetsuya Fujikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Fujikawa. A scholar is included among the top collaborators of Tetsuya Fujikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Fujikawa. Tetsuya Fujikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fujikawa, Tetsuya, Shota Suzuki, Akira Fujiwara, et al.. (2023). Omega-3 Fatty Acids Reduce Remnant-like Lipoprotein Cholesterol and Improve the Ankle–Brachial Index of Hemodialysis Patients with Dyslipidemia: A Pilot Study. Medicina. 60(1). 75–75. 3 indexed citations

Kawai, Yuki, Yoshiyuki Toya, Hiromichi Wakui, et al.. (2021). Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: A randomized controlled trial. Journal of Clinical Hypertension. 23(4). 870–878. 2 indexed citations

Ohki, Kohji, Hiromichi Wakui, Kazushi Uneda, et al.. (2020). Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia. SHILAP Revista de lepidopterología. 6(4). 299–308. 4 indexed citations

Wakui, Hiromichi, Takahiro Yamaji, Kengo Azushima, et al.. (2020). Effects of Rikkunshito treatment on renal fibrosis/inflammation and body weight reduction in a unilateral ureteral obstruction model in mice. Scientific Reports. 10(1). 1782–1782. 6 indexed citations

Kon, Risako, Tetsuya Fujikawa, Takefumi Uemura, et al.. (2018). Laxative action of sennoside A, which causes decreased colonic aquaporin‐3 expression, is controlled by the anti‐inflammatory effect of glycyrrhizin. Traditional & Kampo Medicine. 5(1). 45–50. 4 indexed citations

Kon, Risako, Hiroshi Kimura, Yuta Murakami, et al.. (2018). CPT-11-Induced Delayed Diarrhea Develops via Reduced Aquaporin-3 Expression in the Colon. International Journal of Molecular Sciences. 19(1). 170–170. 23 indexed citations

Hirawa, Nobuhito, Yuki Okuyama, Megumi Fujita, et al.. (2017). Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure. Clinical and Experimental Nephrology. 21(5). 858–865. 15 indexed citations

Azushima, Kengo, Hiromichi Wakui, Kazushi Uneda, et al.. (2017). Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney disease. Clinical and Experimental Hypertension. 39(7). 665–671. 4 indexed citations

Kobayashi, Yusuke, Tetsuya Fujikawa, Hideo Kobayashi, et al.. (2016). Relationship between Arterial Stiffness and Blood Pressure Drop During the Sit-to-stand Test in Patients with Diabetes Mellitus. Journal of Atherosclerosis and Thrombosis. 24(2). 147–156. 13 indexed citations

10.

Azushima, Kengo, Kouichi Tamura, Hiromichi Wakui, et al.. (2013). Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity. PLoS ONE. 8(10). e75560–e75560. 24 indexed citations

11.

Fujikawa, Tetsuya, Yumiko Ikeda, Shunichi Fukuhara, et al.. (2013). Time-Dependent Resistance to Erythropoiesis-Stimulating Agent and Mortality in Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study. Nephron Clinical Practice. 122(1-2). 24–32. 12 indexed citations

12.

Fujikawa, Tetsuya, Yoshiyuki Toya, Yoko Ito, et al.. (2013). Loss of Amino Acids Into Dialysate During Hemodialysis Using Hydrophilic and Nonhydrophilic Polyester–Polymer Alloy and Polyacrylonitrile Membrane Dialyzers. Therapeutic Apheresis and Dialysis. 18(4). 340–346. 14 indexed citations

13.

Ito, Yoko, Tetsuya Fujikawa, Yoshiyuki Toya, et al.. (2012). Effect of Renin‐Angiotensin System Inhibitor on Residual Glomerular Filtration Rate in Hemodialysis Patients. Therapeutic Apheresis and Dialysis. 16(6). 554–559. 7 indexed citations

14.

Fujikawa, Tetsuya, Osamu Tochikubo, Teruyasu Sugano, & Satoshi Umemura. (2012). Accuracy of the pulse delay time technique with triple cuff for objective indirect blood pressure measurement. Journal of Hypertension. 31(2). 278–286. 5 indexed citations

15.

Maeda, Akinobu, Kouichi Tamura, Tomohiko Kanaoka, et al.. (2012). Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker Exerts Pleiotropic Therapeutic Effects in Addition to Blood Pressure Lowering: Amlodipine and Candesartan Trial in Yokohama (ACTY). Clinical and Experimental Hypertension. 34(4). 249–257. 5 indexed citations

16.

Tamura, Kouichi, Mai Yanagi, Tetsuya Fujikawa, et al.. (2012). 755 EFFECTS OF OLMESARTAN ON AMBULATORY BLOOD PRESSURE AND RENAL FUNCTION IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASE. Journal of Hypertension. 30(Supplement 1). e218–e218.

17.

Kanaoka, Tomohiko, Kouichi Tamura, Masato Ohsawa, et al.. (2012). Relationship of Ambulatory Blood Pressure and the Heart Rate Profile with Renal Function Parameters in Hypertensive Patients with Chronic Kidney Disease. Clinical and Experimental Hypertension. 34(4). 264–269. 10 indexed citations

18.

Yanagi, Mai, Kouichi Tamura, Tetsuya Fujikawa, et al.. (2012). The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease. Hypertension Research. 36(3). 262–269. 19 indexed citations

19.

Fujikawa, Tetsuya, et al.. (2009). Factors Related to Elevated 24-h Blood Pressure in Young Adults. Clinical and Experimental Hypertension. 31(8). 705–712. 14 indexed citations

20.

Fujikawa, Tetsuya, et al.. (2009). Measurement of Hemodynamics During Postural Changes Using a New Wearable Cephalic Laser Blood Flowmeter. Circulation Journal. 73(10). 1950–1955. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact